Search Results
Slidesets
Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206 - Valeriane Leroy
Presented at:
International Workshop on HIV & Pediatrics 2015
Slidesets
2019 Update on the HIV Epidemic in Infants, Children, Adolescents and Women - Mary Mahy, ScD, MHSc
Presented at:
International Workshop on HIV & Pediatrics 2019
Slidesets
Reducing HIV associated inflammation – do the drugs matter?- Darrell Tan, BSc, MD, FRCPC, PhD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Reduced drug regimens, what’s the magic number: three, two or one? – Overview- Jonathan Schapiro, MD
Presented at:
Spanish HIV Clinical Forum 2017
Slidesets
Dr. Giuliano Rizzardini - Long-acting ARVs Treatment
Presented at:
European Meeting on HIV & Hepatitis 2021
Slidesets
State of the Art Resistance to INSTI - Anne - Geneviève Marcelin
Presented at:
Chinese HIV Clinical Forum Educational Series 2020 - 2021
Slidesets
High Transmitted Drug Resistance in Brazil Unprecedented Levels of INSTI Resistance - Ricardo Diaz
Presented at:
INTEREST 2022
Slidesets
DDIs with Contraceptives / Gender Affirmation | Kimberly Scarsi
Presented at:
The Liverpool Course 2023